One-year follow-up of MIST I: A prospective, multicenter, randomized, double blind, placebo-controlled trial to evaluate the efficacy of patent foramen ovale closure with the STARFlex (R) septal repair implant to prevent refractory migraine headaches (The MIST III trial): Full data from MIST I